" class="no-js "lang="en-US"> Kevin Conroy - Medtech Alert
Sunday, October 01, 2023
Kevin Conroy

Kevin Conroy

About Kevin Conroy

What excites me most about working at Exact Sciences is solving hard problems with exceptional people. It’s incredibly energizing to know that our collective ability and experience is making a real difference in the early detection of cancer, a space in which few companies have been able to carve out a leadership position. I’m just as excited that we’re putting our skills and know-how to work bringing other products to market where we can make a similar difference.

Related Story

Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Cancer Testing for More Patients

January 10 2022

Exact Sciences Corp. (NASDAQ: EXAS) announced today it has acquired PreventionGenetics, a genetic testing laboratory, to […]

Exact Sciences and Jefferson Health Commence Collaboration on Multi-Cancer Earlier Detection

November 18 2021

Exact Sciences Corp. (NASDAQ: EXAS) today announced an agreement with Jefferson Health (Jefferson) to conduct research on […]